Liraglutide 6 mg/10 mL Injection

Compounded GLP-1 Agonist for Weight Management

Product Overview

This compounded preparation contains liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.

Critical Safety Information

Pregnancy & Lactation Restrictions

Administration & Handling:

Route: Subcutaneous (abdomen, thigh, upper arm) with site rotation.
Missed Dose: Skip if >12 hours late.
Storage: Unopened: 2°C–8°C (36°F–46°F).
In use: =30°C (86°F); discard 30 days after first puncture.
Incompatibilities: Do not mix with other medications.
Monitor for pancreatitis symptoms (severe abdominal pain)

Risks & Warning:

Patient Counseling Essentials

• Do not use if pregnant/trying to conceive; it causes fetal harm.
• Discontinue immediately if pregnancy is suspected.
• Avoid breastfeeding during treatment.
• Monitor for thyroid lumps, pancreatitis symptoms, or suicidal thoughts
• Discard if frozen or discolored.